Markets

Japanese takeover bid lifts Challenger shares to eight-year high

Dai-ichi Life's non-binding offer values Australia's leading retirement income provider at $7.94 billion. Challenger's board is considering the bid.

Office workers walk past the Dai-ichi Life headquarters in Tokyo

The Dai-ichi Life headquarters in Tokyo. Digitally illustrated image.

By Bushletter Newsroom · 19 October 2026

TLDR

Japan's Dai-ichi Life has offered A$11.80 a share to acquire the 79.5 per cent of Challenger it does not already own, valuing Australia's leading annuity provider at about A$7.94 billion. The non-binding proposal carries a 17.7 per cent premium to Challenger's one-month average price, and Challenger's board is now considering the offer.

The offer

TAL Dai-ichi Life Australia Pty Limited, the Australian subsidiary of Dai-ichi Life Group, Inc., put a formal non-binding indicative offer to Challenger Limited's board after market close on Friday 16 October 2026, proposing to acquire the remaining 79.5 per cent of Challenger's ordinary shares by way of a scheme of arrangement at A$11.80 per share.^[1] The offer values Challenger at about A$7.94 billion.

The offer represents a 17.7 per cent premium to Challenger's one-month volume weighted average price of A$10.03.^[1] Challenger shares jumped 16.7 per cent to an eight-year high of A$11.49 in Monday morning trading.

Dai-ichi's existing stake

TAL Dai-ichi Life Australia completed the purchase of a 19.9 per cent equity interest in Challenger on 1 August 2025, receiving all required regulatory approvals on that date.^[2] Dai-ichi Life Holdings confirmed separately that the completion made Challenger an equity-method affiliated company of the group.^[3]

Challenger is an ASX-listed investment management firm founded in 1985, and its Australian Prudential Regulation Authority-regulated life division is Australia's leading annuity provider, converting retirees' savings into guaranteed income streams.

What happens next

The proposal carries several conditions that must all be satisfied before any transaction can proceed, including satisfactory completion of due diligence, entry into a scheme implementation agreement on terms acceptable to both parties, approval from relevant regulatory bodies including the Foreign Investment Review Board, and a recommendation from Challenger's board.^[1]

Challenger's board said it was considering the indicative offer and would continue to keep the market informed in accordance with its continuous disclosure obligations.^[1] Challenger said shareholders do not need to take any action at this stage, and that no certainty exists that the proposal will result in a binding offer or that any transaction will eventuate.^[1]

KEY TAKEAWAYS

01TAL Dai-ichi Life Australia offered A$11.80 per Challenger share, implying total equity of about A$7.94 billion.

02The bid carries a 17.7 per cent premium to Challenger's one-month volume weighted average price of A$10.03.

03TAL Dai-ichi Life Australia completed its initial 19.9 per cent Challenger stake on 1 August 2025.

04The proposal is non-binding and conditional on due diligence, regulatory approvals and a board recommendation.

05Challenger shareholders do not need to act; no certainty exists that a binding offer will follow.

This article contains analysis and commentary on market conditions. It does not constitute financial, investment, or professional advice. Past performance is not indicative of future results. Always consult a qualified adviser before making financial decisions.

SOURCES & CITATIONS

FREQUENTLY ASKED QUESTIONS

What is Dai-ichi Life offering for Challenger?

TAL Dai-ichi Life Australia Pty Limited has offered A$11.80 per share for the 79.5 per cent of Challenger it does not already own, implying a total equity value of about A$7.94 billion. The offer is non-binding and conditional.

How much of Challenger does Dai-ichi Life already own?

TAL Dai-ichi Life Australia owns about 20.5 per cent of Challenger. It completed the purchase of a 19.9 per cent stake on 1 August 2025.

Do Challenger shareholders need to do anything right now?

No. Challenger said shareholders do not need to take any action at this stage and that there is no certainty a binding offer or transaction will eventuate.